ER-100 targets glaucoma and NAION through epigenetic reprogramming, with Phase II trials advancing, highlighting potential economic and healthcare disruptions in anti-aging therapies. Life Biosciences...
Life Biosciences launches a Phase I trial for cellular reprogramming to treat age-related macular degeneration, challenging aging norms with FDA’s Plausible Mechanism Pathway, amid rising invest...
Recent research reveals how mitochondrial decline accelerates cellular senescence in blood vessels, driving conditions like atherosclerosis and blood-brain barrier leakage, with emerging therapies tar...
Recent breakthroughs in senolytic and senomorphic therapies, including polyunsaturated lipids inducing ferroptosis, are advancing clinical trials for age-related diseases, with a focus on safety and b...
Recent studies show Roseburia inulinivorans boosts muscle strength in aging, with probiotics targeting sarcopenia gaining traction in the wellness market amid regulatory and ethical debates. Breakthro...
Recent studies reveal that mild stressors like hypoxia enhance autophagy and epigenetic changes, delaying aging and informing lifestyle interventions and drug development for preventive health. Emergi...
A new study using MRI models shows resistance exercise reduces brain age gaps, enhancing cognitive functions and supporting healthy aging through improved neural connectivity. Recent research highligh...
Recent advancements in cellular reprogramming, including significant funding and clinical trials, are transforming anti-aging science by targeting root causes of age-related diseases. Cellular reprogr...
Recent UK Biobank analysis shows healthy dietary patterns can extend lifespan by 1.5-3.0 years, emphasizing diet as a key modifiable factor for longevity and healthspan extension. New data from UK Bio...
Analyzing the surge in mindfulness and meditation adoption, backed by scientific studies on stress reduction and cognitive benefits, with insights into digital trends and commercialization impacts. As...
